Effects of alfacalcidol on muscle strength, muscle fatigue, and bone mineral density in normal and ovariectomized rats. 2010

Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan. kasukawa@doc.med.akita-u.ac.jp

Vitamin D affects not only bone but also muscle to prevent falls and osteoporotic fractures. However, these effects on muscle and the mechanisms of fall prevention are still unclear. The purpose of this study was to investigate the effects of alfacalcidol [1α(OH)D(3)] on muscle strength, muscle fatigue, and bone mineral density (BMD) in ovariectomized rats. Seven-month-old female Wistar rats were orally administered 1α(OH)D(3) or its vehicle everyday for 4 weeks after ovariectomy (OVX) or sham operation. Calf muscle strength and fatigue were evaluated by electrical stimulation of the sciatic nerve under general anesthesia. 1α(OH)D(3) administration significantly increased the maximum muscle strength in the sham-operated (P < 0.01) and the OVX (P < 0.01) groups compared to their respective control groups. However, 1α(OH)D(3) administration did not significantly affect muscle fatigue in these groups. The BMD of the femur in the 1α(OH)D(3)-treated OVX group was significantly higher than that in the vehicle-treated OVX group (P = 0.04). These results suggested that 1α(OH)D(3) increases muscle strength but does not affect muscle fatigue in this rat model. The effectiveness of activated vitamin D in preventing bone fractures may be partly owing to its effect on muscle strength in addition to its known effect on bone metabolism.

UI MeSH Term Description Entries
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D010052 Ovariectomy The surgical removal of one or both ovaries. Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D050071 Bone Density Conservation Agents Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. Antiresorptive Agent,Antiresorptive Agents,Antiresorptive Drugs,Bone Resorption Inhibitors,Bone Resorption Inhibitory Agents,Agent, Antiresorptive,Inhibitors, Bone Resorption,Resorption Inhibitors, Bone

Related Publications

Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
January 2008, Journal of bone and mineral metabolism,
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
June 2021, Physical activity and nutrition,
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
November 1995, Nihon Seikeigeka Gakkai zasshi,
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
August 2011, Menopause (New York, N.Y.),
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
September 2000, Zhonghua yi xue za zhi,
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
March 2003, Journal of musculoskeletal & neuronal interactions,
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
January 2009, Advances in experimental medicine and biology,
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
December 2009, European journal of obstetrics, gynecology, and reproductive biology,
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
January 2008, Cytotherapy,
Yuji Kasukawa, and Naohisa Miyakoshi, and Shigeto Maekawa, and Koji Nozaka, and Hideaki Noguchi, and Yoichi Shimada
August 1998, Bone,
Copied contents to your clipboard!